Literature DB >> 14741690

Protein kinase PKN1 associates with TRAF2 and is involved in TRAF2-NF-kappaB signaling pathway.

Yusuke Gotoh1, Kumiko Oishi, Hideki Shibata, Akiko Yamagiwa, Takayuki Isagawa, Tamako Nishimura, Emiko Goyama, Mikiko Takahashi, Hideyuki Mukai, Yoshitaka Ono.   

Abstract

PKN1 is a fatty acid and Rho-activated serine/threonine protein kinase whose catalytic domain is highly homologous to protein kinase C (PKC) family. In yeast two-hybrid screening for PKN1 binding proteins, we identified tumor necrosis factor alpha (TNFalpha) receptor-associated factor 2 (TRAF2). TRAF2 is one of the major mediators of TNF receptor superfamily transducing TNF signal to various functional targets, including activation of NF-kappaB, JNK, and apoptosis. FLAG-tagged PKN1 was co-immunoprecipitated with endogenous TRAF2 from HEK293 cell lysate, and in vitro binding assay using the deletion mutants of TRAF2 showed that PKN1 directly binds to the TRAF domain of TRAF2. PKN1 has the TRAF2-binding consensus sequences PXQX (S/T) at amino acid residues 580-584 (PIQES), and P580AQ582A mutant was not co-immunoprecipitated with TRAF2. Furthermore, the reduced expression of PKN1 by RNA interference (RNAi) down-regulated TRAF2-induced NF-kappaB activation in HEK293T cells. These results suggest that PKN1 is involved in TRAF2-NF-kappaB signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14741690     DOI: 10.1016/j.bbrc.2003.12.148

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Identification of an interaction between the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor with protein kinase C-related kinase (PRK) 1: implications for prostate cancer.

Authors:  Elizebeth C Turner; David J Kavanagh; Eamon P Mulvaney; Caitriona McLean; Katarina Wikström; Helen M Reid; B Therese Kinsella
Journal:  J Biol Chem       Date:  2011-02-28       Impact factor: 5.157

2.  Protein kinase N1 is a novel substrate of NFATc1-mediated cyclin D1-CDK6 activity and modulates vascular smooth muscle cell division and migration leading to inward blood vessel wall remodeling.

Authors:  Nikhlesh K Singh; Venkatesh Kundumani-Sridharan; Sanjay Kumar; Shailendra K Verma; Sivareddy Kotla; Hideyuki Mukai; Mark R Heckle; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2012-08-13       Impact factor: 5.157

3.  Development of an intracellularly acting inhibitory peptide selective for PKN.

Authors:  Kazuhiro Shiga; Kentaro Takayama; Shiroh Futaki; Jessica E Hutti; Lewis C Cantley; Katsuko Ueki; Yoshitaka Ono; Hideyuki Mukai
Journal:  Biochem J       Date:  2009-12-23       Impact factor: 3.857

4.  Regulatory domain selectivity in the cell-type specific PKN-dependence of cell migration.

Authors:  Sylvie Lachmann; Amy Jevons; Manu De Rycker; Adele Casamassima; Simone Radtke; Alejandra Collazos; Peter J Parker
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

5.  Protein Kinase C-Related Kinase (PKN/PRK). Potential Key-Role for PKN1 in Protection of Hypoxic Neurons.

Authors:  Bettina Thauerer; Stephanie Zur Nedden; Gabriele Baier-Bitterlich
Journal:  Curr Neuropharmacol       Date:  2014-05       Impact factor: 7.363

Review 6.  TRAF1 Signaling in Human Health and Disease.

Authors:  Maria I Edilova; Ali A Abdul-Sater; Tania H Watts
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

7.  Lack of effect of the Salmonella deubiquitinase SseL on the NF-κB pathway.

Authors:  Francisco S Mesquita; David W Holden; Nathalie Rolhion
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

8.  A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries.

Authors:  Angelika Oehmig; Andrea Klotzbücher; Maria Thomas; Frank Weise; Ursula Hagner; Ralf Brundiers; Dirk Waldherr; Andreas Lingnau; Achim Knappik; Michael H G Kubbutat; Thomas O Joos; Hansjürgen Volkmer
Journal:  BMC Genomics       Date:  2008-09-24       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.